Skip to content
2000
Volume 17, Issue 1
  • ISSN: 1871-5257
  • E-ISSN: 1875-6182

Abstract

Artificial blood is an innovative concept of transfusion medicine where specifically designed compounds perform the task of transport and delivery of oxygen in the body to replace this function of allogenic human blood transfusion. Several molecules have been developed in the past few decades to achieve this objective and continous refinements are being continuously made in the quest of the ideal blood substitute. Currently, available technology manufactures artificial blood from haemoglobin obtained from outdated human/bovine blood (Haemoglobin Based Oxygen Carriers) or utilizing Perfluorocarbons. These synthetic blood substitutes are advantageous in that they do not require compatibility testing, are free from blood borne infections, have prolonged shelf life and do not require refrigeration. Artificial blood is projected to have a significant impact on the development of medical care in the future. It can complement the current blood products for transfusion and create a stable supply of safe and effective products. It is likely to reduce the requirements of blood transfusions drastically especially in settings of trauma and surgery thereby reducing the reliance on banked donated blood.

Loading

Article metrics loading...

/content/journals/chamc/10.2174/1871525717666190617120045
2019-05-01
2025-12-09
Loading full text...

Full text loading...

/content/journals/chamc/10.2174/1871525717666190617120045
Loading

  • Article Type:
    Review Article
Keyword(s): Anaemia; blood; erythrocytes; haemoglobin; hypersensitivity; liposomes; resuscitation; transfusion
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test